Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. 2003

Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplantation, Minneapolis, MN, USA. blaza001@tc.umn.edu

OX40 (CD134) is expressed on activated T cells; its ligand, OX40 ligand (OX40L) is expressed on dendritic cells, B cells, and activated endothelial cells. To determine how OX40-OX40L interaction affects graft-versus-host disease (GVHD), we used antagonistic anti-OX40L monoclonal antibody (mAb) or OX40(-/-) donor or OX40L(-/-) recipient mice. Similar degrees of GVHD reduction were observed with each approach. Despite the fact that OX40 is up-regulated on both CD4(+) and CD8(+) T cells isolated during GVHD, the major effects of OX40 ligation were on CD4(+) and not CD8(+) T-cell-mediated alloresponses as assessed in both GVHD and engraftment model systems. GVHD inhibition by blockade of the OX40/OX40L pathway did not require CD28 signaling. Some studies have indicated OX40 is essential for inducing T-helper type 2 (Th2) responses. However, in vivo blockade of OX40-OX40L interactions reduced GVHD mortality induced by either signal transducer and activator of transcription-6(-/-) (Stat-6(-/-)) (Th2-defective) or Stat-4(-/-) (Th1-defective) major histocompatibility complex (MHC)-disparate splenocytes, indicating that the GVHD-ameliorating effects did not require Stat-4 or Stat-6 signaling. Although OX40L has been reported to be expressed on activated T cells, no effects on GVHD were observed when OX40L(-/-) versus OX40L(+/+) T cells were infused in different models. These data provide insights as to the mechanisms responsible for OX40/OX40L regulation of GVHD.

UI MeSH Term Description Entries
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011828 Radiation Chimera An organism whose body contains cell populations of different genotypes as a result of the TRANSPLANTATION of donor cells after sufficient ionizing radiation to destroy the mature recipient's cells which would otherwise reject the donor cells. Chimera, Radiation,Chimeras, Radiation,Radiation Chimeras
D003433 Crosses, Genetic Deliberate breeding of two different individuals that results in offspring that carry part of the genetic material of each parent. The parent organisms must be genetically compatible and may be from different varieties or closely related species. Cross, Genetic,Genetic Cross,Genetic Crosses
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
March 2001, Journal of immunology (Baltimore, Md. : 1950),
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
June 1994, Transplant immunology,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
February 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
March 2002, Journal of cataract and refractive surgery,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
January 1994, Bone marrow transplantation,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
April 2000, Blood,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
September 2004, British journal of haematology,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
March 2003, BMC gastroenterology,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
January 2000, Paediatric drugs,
Bruce R Blazar, and Arlene H Sharpe, and Andy I Chen, and Angela Panoskaltsis-Mortari, and Christopher Lees, and Hisaya Akiba, and Hideo Yagita, and Nigel Killeen, and Patricia A Taylor
March 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology,
Copied contents to your clipboard!